| 000 | 01582 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516133736.0 | ||
| 264 | 0 | _c20130719 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0055706 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNevalainen, Nina | |
| 245 | 0 | 0 |
_aStriatal glutamate release in L-DOPA-induced dyskinetic animals. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae55706 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a8-Hydroxy-2-(di-n-propylamino)tetralin _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenserazide _xadverse effects |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT1A _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLundblad, Martin | |
| 700 | 1 | _aGerhardt, Greg A | |
| 700 | 1 | _aStrömberg, Ingrid | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 2 _gp. e55706 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0055706 _zAvailable from publisher's website |
| 999 |
_c22486198 _d22486198 |
||